Related Experiment Video

Updated: Jun 23, 2026

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

Regulation of the cytoskeleton: an oncogenic function for CDK inhibitors?

Arnaud Besson1, Richard K Assoian, James M Roberts

  • 1Howard Hughes Medical Institute, Fred Hutchinson Cancer Research Center, Division of Basic Science, Seattle, Washington 98109, USA.

Nature Reviews. Cancer
|December 2, 2004
PubMed

Insights

Cyclin-dependent kinase inhibitors (CKIs) regulate cell proliferation. Upregulated cytoplasmic CKIs in cancer cells may drive tumor invasion and metastasis, suggesting novel therapeutic targets.

Area of Science:

  • Cell Biology
  • Molecular Oncology
  • Cancer Research

Background:

  • Cyclin-dependent kinase inhibitors (CKIs) are recognized regulators of cell proliferation.
  • Disruption of CKI activity is a common event in various tumor types.
  • Emerging evidence suggests non-canonical roles for CKIs beyond cell cycle control.

Purpose of the Study:

  • To investigate the alternative functions of CKIs in cancer.
  • To explore the role of cytoplasmic CKIs in regulating cell migration.
  • To determine the potential involvement of cytoplasmic CKI activity in tumor metastasis.

Main Methods:

  • Analysis of CKI expression and localization in cancer cells.
  • Investigating CKI interactions with Rho signaling pathways.
  • Assessing the impact of CKI modulation on cytoskeletal organization and cell motility.

Main Results:

  • Some CKIs exhibit cytoplasmic functions distinct from their nuclear roles.
  • Cytoplasmic CKIs regulate Rho signaling, influencing cytoskeletal dynamics.
  • Upregulation of cytoplasmic CKIs correlates with enhanced cell migration and potential for metastasis.

Conclusions:

  • While loss of nuclear CKI function promotes cancer cell proliferation, increased cytoplasmic CKI activity may contribute to tumor invasion.
  • Cytoplasmic CKI functions represent a potential new avenue for therapeutic strategies targeting cancer metastasis.

More Related Videos

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols12:02

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols

Published on: June 6, 2017

Related Concept Videos

Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...